UTERINE CERVICAL NEOPLASMS
Clinical trials for UTERINE CERVICAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UTERINE CERVICAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UTERINE CERVICAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat HER2 cancers
Disease control OngoingThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with advanced solid tumors that have HER2 alterations (too much or a different type of HER2 protein). The tumors have spread or cannot be removed by surgery. The main goal is to see if the treatment…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Phase: PHASE2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 17, 2026 04:31 UTC
-
DNA bank aims to unlock family cancer secrets
Knowledge-focused OngoingThis study collects blood and saliva samples from people with cancer and their family members to build a DNA bank. Researchers will use these samples to study how genes may increase the risk of developing certain cancers. The goal is to better understand inherited cancer tendenci…
Matched conditions: UTERINE CERVICAL NEOPLASMS
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 04:34 UTC